Search results for " Post-Translational"

showing 10 items of 148 documents

Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells

2002

Resveratrol is a natural polyphenolic compound produced by a number of plants and found in high amount in peanuts, seeds, grapes or berries as source of human nutrition. Epidemiological studies strongly suggest that resveratrol may act as a cancer chemopreventive compound. The mechanism by which resveratrol inhibits cell proliferation was studied in human colorectal tumor SW480 cell line. The results show that resveratrol strongly inhibits cell proliferation at the micromolar range in a time- and dose-dependent manner. Resveratrol appears to block the cell cycle at the transition --> G2/M since inhibition of [(3)H]-thymidine incorporation is not observed, while there is an increase of the c…

DNA Replicationendocrine system diseasesCellCyclin AAdenocarcinomaCyclin BProtein Serine-Threonine KinasesResveratrolS Phasechemistry.chemical_compoundCDC2 Protein KinaseStilbenesCDC2-CDC28 KinasesTumor Cells CulturedGeneticsmedicineAnticarcinogenic AgentsHumansCyclin B1Phosphorylationskin and connective tissue diseasesCyclinCyclin-dependent kinase 1biologyKinaseCell growthorganic chemicalsCell CycleCyclin-Dependent Kinase 2Cyclin-dependent kinase 2food and beveragesGeneral MedicineCell cycleFlow CytometryCyclin-Dependent KinasesGrowth InhibitorsNeoplasm ProteinsGene Expression Regulation Neoplasticmedicine.anatomical_structureBiochemistrychemistryResveratrolEnzyme Inductionbiology.proteinCancer researchColorectal NeoplasmsProtein Processing Post-TranslationalCell DivisionInternational Journal of Molecular Medicine
researchProduct

Constitutive Promoter Occupancy by the MBF-1 Activator and Chromatin Modification of the Developmental Regulated Sea Urchin α-H2A Histone Gene

2007

The tandemly repeated sea urchin alpha-histone genes are developmentally regulated. These genes are transcribed up to the early blastula stage and permanently silenced as the embryos approach gastrulation. As previously described, expression of the alpha-H2A gene depends on the binding of the MBF-1 activator to the 5' enhancer, while down-regulation relies on the functional interaction between the 3' sns 5 insulator and the GA repeats located upstream of the enhancer. As persistent MBF-1 binding and enhancer activity are detected in gastrula embryos, we have studied the molecular mechanisms that prevent the bound MBF-1 from trans-activating the H2A promoter at this stage of development. Her…

Embryo Nonmammaliananimal structuresRestriction MappingMBF-1Down-RegulationEnhancer RNAschromatin immunoprecipitationBiologyHistone DeacetylasesactivatorHistonesHistone H3Histone H1Structural BiologyHistone H2AHistone methylationAnimalsNucleosomeHistone codenucleosome phasingPromoter Regions GeneticEnhancerBase PairingMolecular Biologyhistone modificationsGene Expression Regulation DevelopmentalGastrulaMolecular biologyChromatinNucleosomesRepressor ProteinsMutagenesis InsertionalEnhancer Elements GeneticSea Urchinsembryonic structuresTrans-ActivatorsCalmodulin-Binding ProteinsInsulator Elementssea urchin histone geneProtein Processing Post-TranslationalProtein BindingJournal of Molecular Biology
researchProduct

Synthesis and Structure-Activity Relationships of Amino Acid Conjugates of Cholanic Acid as Antagonists of the EphA2 Receptor

2013

The Eph–ephrin system plays a critical role in tumor growth and vascular functions during carcinogenesis. We had previously identified cholanic acid as a competitive and reversible EphA2 antagonist able to disrupt EphA2-ephrinA1 interaction and to inhibit EphA2 activation in prostate cancer cells. Herein, we report the synthesis and biological evaluation of a set of cholanic acid derivatives obtained by conjugation of its carboxyl group with a panel of naturally occurring amino acids with the aim to improve EphA2 receptor inhibition. Structure-activity relationships indicate that conjugation of cholanic acid with linear amino acids of small size leads to effective EphA2 antagonists whereas …

EphA2 antagonistsStereochemistryStructure-activity relationship studiesPharmaceutical Sciencemedicine.disease_causeArticleProtein Structure SecondaryAnalytical Chemistrylcsh:QD241-441Inhibitory Concentration 50Structure-Activity Relationshipchemistry.chemical_compoundamino acid conjugateslcsh:Organic chemistryEphA2 anatgonistscholanic acid; amino acid conjugates; EphA2 antagonists; structure-activity relationshipsCell Line TumorDrug DiscoveryAromatic amino acidsmedicineHumansPhosphorylationPhysical and Theoretical ChemistryReceptorbile acids; EphA2 anatgonists; Structure-activity relationship studies; amino acid conjugatesbile acidschemistry.chemical_classificationBinding SitesReceptor EphA1Receptor EphA2structure-activity relationshipsOrganic ChemistryAntagonistCholic AcidsHydrogen BondingEPH receptor A2Amino acidMolecular Docking SimulationCholanic acidcholanic acidchemistryBiochemistryChemistry (miscellaneous)Molecular MedicineCarcinogenesisProtein Processing Post-TranslationalProtein BindingConjugateMolecules
researchProduct

Epigenetic biomarkers: A new perspective in laboratory diagnostics.

2012

Epigenetics comprises the study of chemical modifications in the DNA and histones that regulates the gene expression or cellular phenotype. However, during the last decade this term has evolved after the elucidation of different mechanisms (microRNAs and nuclear organization of the chromosomes) involved in regulating gene expression. Epigenetics and the new designed technologies capable to analyze epigenetic changes (e.g., methylated DNA, miRNAs expression, post-translational modifications on histones among others) have disclosed an appealing scenario that will offer for the biomedical sciences new biomarkers for the study of neurodegenerative diseases, multifactorial complex diseases, rare…

EpigenomicsClinical BiochemistryBiologyBiochemistryEpigenesis GeneticHistonesmicroRNACancer; DNA methylation; Histone; MiRNAs; Rare disease;HumansEpigeneticsPathology MolecularEpigenesisEpigenomicsCancerGeneticsEpigenetic biomarkersBiochemistry (medical)Nuclear organizationGeneral MedicineSequence Analysis DNADNA MethylationHistoneMicroRNAsHistoneDNA methylationbiology.proteinMiRNAsRare diseaseProtein Processing Post-TranslationalBiomarkersClinica chimica acta; international journal of clinical chemistry
researchProduct

Enzymes involved in the dynamic equilibrium of core histone acetylation ofPhysarum polycephalum

1992

DEAE-Scpharose chromatography of extracts from plasmodia of the myxomyccte PI~.~suru~~t ,~/.~crpl~~ho~~ revealed the presence of multiple histone acetyltransferases and histonc deacctylascs. A cyloplasmic histonc acctyltransferase B, specific for histonc H4, and two nuclear acetyltransferases Al and A2 were identilied; Al acetylates all core hislones with a preference for l-13 and H2A. whereas A2 is specific for H3 and also slightly for H2B. Two hislone deacetylases. HDI and HD2, could be discriminated. They differ with respect to subslralc speciliciiy and pH dependence. For the first time the substrate specificity of histonc deacetylascs was determined using HPLC-purilicd individual core h…

ErythrocytesSaccharomyces cerevisiae ProteinsBiophysicsBiochemistryHistone DeacetylasesSubstrate SpecificityHistonesPhysarumHistone H1AcetyltransferasesPhysarum polycephalumStructural BiologyHistone H2AGeneticsAnimalsHistone deacetylaseHistone octamerMolecular BiologyChromatography High Pressure LiquidHistone AcetyltransferasesHistone AcetyltransferasesbiologyHistone deacetylase 2AcetylationButyrateCell BiologyHistone acetyltransferaseMolecular biologyChromatinHistone Deacetylase InhibitorsIsoenzymesButyratesKineticsHistone acetylationBiochemistryHistone methyltransferasebiology.proteinButyric AcidHistone acetyltransferaseHistone deacetylaseChickensProtein Processing Post-TranslationalFEBS Letters
researchProduct

Histone post-translational modifications as potential therapeutic targets for pain management

2021

Effective pharmacological management of pain associated with tissue pathology is an unmet medical need. Transcriptional modifications in nociceptive pathways are pivotal for the development and the maintenance of pain associated with tissue damage. Accumulating evidence has shown the importance of the epigenetic control of transcription in nociceptive pathways via histone post-translational modifications (PTMs). Hence, histone PTMs could be targets for novel effective analgesics. Here, we discuss the current understanding of histone PTMs in the modulation of gene expression affecting nociception and pain phenotypes following tissue injury. We also provide a critical view of the translationa…

Farmacologiadorsal root ganglionPharmacological managementPainToxicologyBioinformaticsHistonesTissue damageHumansPain ManagementMedicinenociceptionPharmacology & PharmacyEpigeneticsspinal dorsal horn11 Medical and Health Sciencesneuropathic painPharmacologyepigeneticsbiologybusiness.industry06 Biological SciencesPain managementgene transcriptionNociceptionHistoneNeuropathic painPosttranslational modificationbiology.proteinbusinessProtein Processing Post-TranslationalGenèticaTrends in Pharmacological Sciences
researchProduct

Posttranslational N-glycosylation of the hepatitis B virus large envelope protein

2007

Abstract Background The addition of N-linked glycans to proteins is normally a cotranslational process that occurs during translocation of the nascent protein to the endoplasmic reticulum. Here, we report on an exception to this rule occurring on the hepatitis B virus (HBV) large L envelope protein that is a subject to co-plus posttranslational N-glycosylation. Results By using an improved detection system, we identified so far unrecognized, novel isoforms of L. Based on mutational analyses, the use of N-glycosylation inhibitors, and pulse-chase studies, we showed that these isoforms are due to posttranslational N-glycan addition to the asparagines 4 and 112 within the preS domain of L. Whi…

Gene Expression Regulation ViralHepatitis B virusGlycosylationGlycosylationViral transformationBiologymedicine.disease_causeHepatitis B virus PRE betaCell Linelcsh:Infectious and parasitic diseaseschemistry.chemical_compoundViral Envelope ProteinsN-linked glycosylationViral entryVirologymedicineHumansProtein Isoformslcsh:RC109-216Hepatitis B viruschemistry.chemical_classificationResearchEndoplasmic reticulumEpithelial CellsVirologyProtein Structure TertiaryCell biologycarbohydrates (lipids)Infectious DiseaseschemistryGlycoproteinProtein Processing Post-TranslationalVirology Journal
researchProduct

Interaction mechanism of endogenous PP2A inhibitor protein ENSA with PP2A

2022

The vast diversity of protein phosphatase 2A (PP2A) holoenzyme composition ensures its multifaceted role in the regulation of cellular growth and signal transduction. In several pathological conditions, such as cancer, PP2A is inhibited by endogenous inhibitor proteins. Several PP2A inhibitor proteins have been identified, one of which is α-endosulfine (ENSA). ENSA inhibits PP2A activity when it is phosphorylated at Ser67 by Greatwall (Gwl) kinase. The role of ENSA in PP2A inhibition is rather well characterized, but knowledge of the mechanism of inhibition is scarce. In this study, we have performed comprehensive structural characterization of ENSA, and its interaction with PP2A A- and var…

Gene isoformMitosisEndogenymacromolecular substancesProtein Serine-Threonine KinasesPP2A inhibitor protein010402 general chemistry01 natural sciencesBiochemistryenvironment and public health03 medical and health sciencesX-Ray DiffractionNeoplasmsScattering Small AngleHumansProtein Phosphatase 2DPsPhosphorylationNMR-spektroskopiaMolecular BiologyNuclear Magnetic Resonance Biomolecular030304 developmental biologyinhibiittoritsoluviestintä0303 health sciencesChemistryKinaseCell growthCell CycleCell BiologyProtein phosphatase 2Inhibitor proteinSAXSPhosphoproteinsNMR3. Good health0104 chemical sciencesCell biologyPP2Aenzymes and coenzymes (carbohydrates)ENSAPhosphorylationIntercellular Signaling Peptides and ProteinsproteiinitSignal transductionMicrotubule-Associated ProteinsProtein Processing Post-TranslationalSignal TransductionFEBS Journal
researchProduct

Rat mammary-gland transferrin: nucleotide sequence, phylogenetic analysis and glycan structure

1995

The complete cDNA for rat mammary-gland transferrin (Tf) has been sequenced and also the native protein isolated from milk in order to analyse the structure of the main glycan variants present. A lactating-rat mammary-gland cDNA library in lambda gt10 was screened with a partial cDNA copy of rat liver Tf and subsequently rescreened with 5′ fragments of the longest clones. This produced a 2275 bp insert coding for an open reading frame of 695 amino acid residues. This includes a 19-amino acid signal sequence and the mature protein containing 676 amino acids and one N-glycosylation site in the C-terminal domain at residue 490. Phylogenetic analysis was carried out using 14 translated Tf nucle…

GlycanDNA ComplementaryGlycosylationMolecular Sequence DataOligosaccharidesSequence alignmentAnimal Population GroupsBiochemistrychemistry.chemical_compoundMammary Glands AnimalSugar AlcoholsSpecies SpecificityPolysaccharidesComplementary DNANeuraminic acidCarbohydrate ConformationAnimalsRats WistarMolecular BiologyPhylogenyBase SequencebiologycDNA libraryTransferrinNucleic acid sequenceCell BiologyMilk ProteinsMolecular biologyN-Acetylneuraminic AcidRatsSialic acidMilkCarbohydrate SequenceGeneschemistryBiochemistryMultigene FamilySialic Acidsbiology.proteinFemaleNeuraminic AcidsProtein Processing Post-TranslationalSequence AlignmentN-Acetylneuraminic acidResearch ArticleBiochemical Journal
researchProduct

LRP1 modulates APP trafficking along early compartments of the secretory pathway

2008

The amyloid beta peptide (A beta) is a central player in Alzheimer's disease (AD) pathology. A beta liberation depends on APP cleavage by beta- and gamma-secretases. The low density lipoprotein receptor related protein 1 (LRP1) was shown to mediate APP processing at multiple steps. Newly synthesized LRP1 can interact with APP, implying an interaction between these two proteins early in the secretory pathway. We wanted to investigate whether LRP1 mediates APP trafficking along the secretory pathway, and, if so, whether it affects APP processing. Indeed, the early trafficking of APP within the secretory pathway is strongly influenced by its interaction with the C-terminal domain of LRP1. The …

GlycosylationAmyloid betaAmino Acid MotifsPlaque AmyloidCHO CellsSecretory pathwayTrafficinglcsh:RC321-571Amyloid beta-Protein PrecursorCricetulusAlzheimer DiseaseCricetinaemental disordersAmyloid precursor proteinAnimalsHumansReceptorlcsh:Neurosciences. Biological psychiatry. NeuropsychiatrySecretory pathwayNeuronsAmyloid beta-PeptidesbiologyLow density lipoprotein receptor related proteinBrainLRP1Cell CompartmentationProtein Structure TertiaryCell biologyProtein TransportNeurologyBiochemistryAlpha secretaseRetentionAmyloid precursor proteinLDL receptorbiology.proteinLiberationProtein Processing Post-TranslationalLow Density Lipoprotein Receptor-Related Protein-1Signal TransductionNeurobiology of Disease
researchProduct